NEW YORK (GenomeWeb News) – PathoGenetix today said it has signed a collaborative agreement with the US Food and Drug Administration to evaluate the company's technology for use in foodborne illness outbreak investigation and response.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.